8-K2.029.01
8-K exhibit
EDGARKiniksa Pharmaceuticals Ltd (KNSA) SEC filings
Kiniksa Pharmaceuticals Ltd (KNSA) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported KNSA revenue for 2025-09-30 was $180.9M. Net income was $44.8M. Revenue was up 15.3% from 2025-06-30 to 2025-09-30. KNSA currently screens at market cap $3.73B and trailing P/E 53.2. The KNSA filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Kiniksa Pharmaceuticals Ltd said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
3
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all KNSA filings.
Frequently asked questions
What did KNSA just say?
KNSA cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are KNSA SEC filings?
3 cached filings are on this page. EDGAR remains the official archive (CIK 0001730430).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.